Mice with pancreas-specific Brsk2 deletion exhibit oral glucose intolerance but maintain normal glucose excursion after intraperitoneal (i.p.) glucose injection due to loss of the gut hormone GLP-1 (Nie et al., 2013b). The gene discussed is BRSK2; the disease is Glucose intolerance.